Print Page   |   Sign In   |   Register
Blog Home All Blogs
Search all posts for:   


View all (127) posts »

Stock Market Manager Weekly Update: July 24th, 2019

Posted By Administration, Friday, July 26, 2019

SMM Logo





Weekly Update: July 24th, 2019








Black Swan Connection Newsletter Signup

Breaking News

Investopia July-25-19

CEO Musk's Dream Is Fading As Tesla Losses Mount

Many Tesla Inc. (TSLA) investors for years have forecasted that the electric car maker led by CEO Elon Musk would finally enter a path of sustained profitability. Instead, Tesla reported a loss of $1.12 per share, far bigger than any analyst had expected, Bloomberg reports. If that were not enough, CEO Musk announced during his earnings call that J.B. Straubel, Tesla's chief technical officer (CTO), is leaving that position to become an "adviser" to the company.

Read Complete Article


7-16-19 Antibe Therapeutics, Inc. TSXV:ATE, OTCQB:ATBPF)

Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV:ATE, OTCQB:ATBPF) filed its financial and operating results on Tuesday, July 16 for the fourth quarter and the year ended March 31, 2019. The Company's audited 2019 consolidated financial statements, MD&A and AIF are available on SEDAR.

About Antibe Therapeutics Inc.
Antibe develops safer, non-addictive medicines for pain and inflammation. Antibe’s technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine. Antibe’s lead drug ATB-346 targets the global need for a safer, non-addictive drug for chronic pain and inflammation.

Read Complete Press Release


7-11-19 Trickle Research issues update and allocation increase to 7
AzurRx Biopharma, Inc.  NASDAQ AZRX
12-24 Month Price Target $10.25

AZRX made the following announcement the other day regarding a new clinical trial they are preparing. They also hosted a call to discuss the logic behind the trial. Here is that release: AzurRx BioPharma Announces Initiation of Phase 2 Clinical Study for MS1819-SD in combination with standard PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

  • Dose escalation study of MS1819-SD in combination with standard porcine pancreatic enzyme replacement therapy (PERT) in CF patients with severe exocrine pancreatic insufficiency (EPI)
  • .Patients in study have persistent malnutrition and clinical symptoms of fat malabsorption despite being on the maximum daily doses of PERTs.
  • First patient visits have been completed in Hungary.
  • Preliminary data expected in early 2020.

NEW YORK, July 08, 2019 (GLOBE NEWSWIRE) --AzurRx BioPharma, Inc. (AZRX) (AzurRx or the Company), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has initiated a Phase 2 clinical trial to investigate MS1819-SD in combination with standard porcine enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF) that suffer from severe exocrine pancreatic insufficiency (EPI), but continue to experience clinical symptoms of fat malabsorption despite taking the maximum daily dose of PERTs.

Read Complete Report


7-10-19 Endurance Exploration Group, Inc. (EXPL)
BWVI and EXPL Continue to Work Through 2019 Season

Jacksonville FL, July 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Blue Water Ventures International, Inc. (BWVI) and project partner Endurance Exploration Group, Inc. (EXPL), are well into the 2019 recovery season on the SB Pulaski.   The SB Pulaski sank in 1838 while in route from Savannah, Georgia to Baltimore, Maryland.  She carried some of the South’s wealthiest families.  The shipwreck was considered the “Titanic” of its’ day.  

The Blue Water Rose has been based out of Wrightsville Beach, North Carolina since mid June.  As weather permits, on site excavations have continued with the recovery of more silver and copper coins; most from US origins, a small gold pocket watch, silver ware and wreck material.  A more detailed survey of bottom conditions has shown Hurricane Florence (September 2018) had a bigger impact on the seabed than was earlier believed.   The Blue Water dive team will continue with a methodical recovery plan to ensure that the entire wreck area will be thoroughly recorded and searched.  Keith Webb, President of Blue Water Ventures International, states, “We are very encouraged with the magnetometer results that were conducted in June and have now established the debris line which should unlock the Pulaski’s secrets.” 

Read Complete Press Release


6-12-19 Canbiola, Inc. (CANB)
Canbiola Presentation from Annual Shareholder Meeting is Publicly Available

HICKSVILLE, NY, July 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola,Inc. (OTCQB: CANB)(“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that its presentation from its Annual Shareholder Meeting held on Friday, June 14, is now publicly available.

We encourage you to read the filing at:

Canbiola Chief Executive Officer Marco Alfonsi commented, “We want to thank all of our shareholders, especially the 100+ that attended our meeting a couple of weeks ago. Our entire team was thrilled with the turn out and enthusiasm.

Read Complete Press Release


6-12-19 Canbiola, Inc. (CANB)
Canbiola and Shi Farms Execute Letter of Intent to Form Joint Venture for Hemp Cultivation & Processing

Plans to Open a NY Depot for Hemp Cultivation

HICKSVILLE, NY, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that has entered into a non-binding Letter of Intent (the “LOI”) with Shi Farms, Inc. (“Shi Farms”), a licensed Hemp Cultivation Operation under the Colorado Department of Agriculture, operating a 300-acre farm and 40,000 square feet of research greenhouses to grow, cultivate, accumulate and process hemp in New York State under a license from Shi Farms. 

For more information about Shi Farms, please visit:

Read Complete Press Release


6-6-2019 Greenridge Global Equity Research Issues Update Guangdong Land Holdings, Ltd. HKSE 0124
Maintaining rating and Buy target HK$ 4.75

Hou Wailin Joins GDL As Chairman Of The Board

Hou Wailin Joins GDL as Chairman of the Board.  Effective yesterday, June 5, Chairman Huang Xiaofeng tendered his resignation as Non-Executive Director and Chairman of the Board after reaching his retirement age.  Chairman Huang served in these positions for roughly ten years and oversaw the transition from Kingway Brewery to a real estate development firm.  Concurrent with this announcement, Mr. Hou Wailin was appointed Non-Executive Director and Chairman of the Board.  Mr. Hou was appointed Chairman of Guangdong Holdings and GDH Limited, the ultimate parent companies of GDL, in May 2019.  Previous experience includes serving as Chairman of Guangdong Technology Financial Group and as Director-General of Guangdong Regulatory Bureau of the China Securities Regulatory Commission (“CSRC”) and Chief Inspector of the General Inspection Taskforce of CSRC.  Similar to Chairman Huang, Chairman Hou will not receive any compensation for this position.  We do not expect any significant shifts in the direction of GDL with this change.

AGM Today.  The AGM will be held later today (June 6, 2019) at 3pm in the Concord Room of the Renaissance Hotel in Wan Chai.

Model Update.  We have made no changes to our model as we expect a continuation of the current business model.

Maintaining Rating & Target.  With no changes to our model we are reiterating our Buy rating and HK$4.75 target price on Guangdong Land.  We continue to believe the current share price does not accurately reflect the underlying value of the Company’s real estate portfolio or the GDH City project.  Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.

Read Complete Report


 6-4-19 Trickle Research Issues Allocation Update Report
Summit Wireless Technologies, Inc.  Nasdaq (WISA) 
12-24 Month Price Target $9.25

Allocation 5

Summit recently completed a secondary offering of roughly 4.1 million shares at $1.33 per share for gross proceeds of about $5.4 million. We are pleased that they were able to put some additional needed working capital in the bank, although we were not particularly happy about the pricing it was done at. We won’t re-beat the dead horse, but as we have noted many times, for small emerging companies like Summit that are dependent on equity raises until they can advance the business to positive cash flow, the specter of unknown amounts of additional dilution can provide significant headwinds for share prices. Below is some narrative we provided in our recent conference overview of the Company, that we think is still germane and provides a good backdrop for our allocation increase: We commenced coverage of Summit in September 2018 with a 12-24 month price target of $9.25.

Click Here for Complete Report

Donald Capital, LLC, A New Investment Bank Opens Its Doors

NEW YORK, May 16, 2019 (GLOBE NEWSWIRE) – Donald Capital, LLC has launched today as a FINRA member Investment Bank. Founded with the intent to build a legacy based upon the fundamentals of honesty and integrity.

Donald Capital will focus on a market that has not been properly served for some time – the Private, Micro, Small & Mid Cap Markets. 

Co-founders Alex Hamilton and Don McDonald have launched several initiatives over their extensive careers to serve this part of the market.  They are very familiar with the challenges facing companies in this market and have the unique perspective to provide solutions.

Read Complete Press Release


New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added a new very important distribution partner in Quote Media.

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.








(listing, quotes, news, research)





Alvopetro Energy, Ltd. (ALVOF)





Antibe Therapeutics, Inc (ATBPF)





AzuerRx Biopharma, Inc. (AZRX)




Camino Minerals Corp. (CAMZF)




Canbiola, Inc. (CANB)





Clean Coal Technologies, Inc (CCTC)




Command Center , Inc. (CCNI)




Endurance Exploration Group, Ltd (EXPL)









Guangdong Land Holdings Limited (124) HK



H-Source Holdings, Ltd (HSCHF)



Petroshare Corp. (PRHR)




Summit Wireless Technologies, Inc.




Social Reality, Inc. (SRAX)








July 19th, 2019

ValuEngine Weekly Report

By: Paul Henneman

ValuEngine Market Valuation update for the week of July 19, 2019. Stock pick of the week is ticker GLPG (Galapagos-ADR). It is a biotech company with a big increase in stock price since ValuEngine first updgraded it to a Strong Buy in mid 2018. There still may be some upside, although riskier now. Read on for more and full updated market/sector numbers for the week. to log in, or free two-week full trial. Over 5,000 stocks, 16 sector groups, 140 plus industries covered every day.

Read Complete Report


Categories Uncategorized, Weekly NewsletterTags market valuations, markets, sector, sector valuations, sectors, stock market, stock pick, STRONG BUY, STRONG BUY stocks, valuations, valuengine, ZNGA, Zynga

VALUATION WATCH: Overvalued stocks now make up 35.94% of our stocks assigned a valuation and 12.85% of those equities are calculated to be overvalued by 20% or more.


To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners


Black Swan Research Coverage and Subscription Service
Click Here>>


Event Calendar Updates

The National Investment Banking Association (NIBA) is proud to host its 147th investment conference on November 12-13, 2019 at The Westin New York at Times Square in New York, NY.

Click Here for Details


Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

-SMM Distribution Update-

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

Note*  Our Instagram acct was recently hacked so we had to start over again.

We have also cleansed our email database of subscribers who haven’t opened for some time and or have errors or other delivery issues with their email.

Black Swan Connection Newsletter Signup


This post has not been tagged.

Share |
Permalink | Comments (0)
Community Search
Sign In


The upcoming calendar is currently empty.

Click here to view past events and photos »